Röhrl Clemens, Fruhwürth Stefanie, Schreier Sabine Maria, Lohninger Alfred, Dolischka Andrea, Hüttinger Manfred, Zemann Nina, Hermann Marcela, Strobl Witta, Stangl Herbert
Center for Physiology and Pathophysiology, Department of Medical Chemistry, Medical University of Vienna, Währingerstrabetae 10, 1090 Vienna, Austria.
Biochim Biophys Acta. 2010 Feb;1801(2):198-204. doi: 10.1016/j.bbalip.2009.11.005. Epub 2009 Nov 22.
Recent evidence suggests that scavenger receptor, class B, type I (SR-BI) plays a physiological role in VLDL metabolism. SR-BI was reported to mediate beta-VLDL uptake; however, cellular details of this process are not well characterized. In the present study we show that SR-BI delivers cholesterol derived from beta-VLDL to LDL receptor negative SR-BI over-expressing Chinese Hamster Ovarian cells (ldlA7-SRBI). Cell association of beta-VLDL was approximately 3 times higher after SR-BI over-expression, which was competed by beta-VLDL, but only to a lesser extent by HDL and LDL. Almost all of the associated beta-VLDL was located intracellularly, and therefore could not be released by a 50-fold excess of unlabeled beta-VLDL. beta-VLDL was degraded at a rate of 6 ng beta-VLDL/mg cell protein and hour. In contrast to ldlA7 cells, beta-VLDL association was competed by LDL in cells with a functional LDL receptor like CHO and HepG2 cells, indicating a strong impact of the LDL receptor in beta-VLDL uptake. beta-VLDL degradation was similar to ldlA7-SRBI cells. When beta-VLDL uptake was followed using fluorescence microscopy, beta-VLDL showed a different uptake pattern in SR-BI over-expressing cells, ldlA7-SRBI, compared to LDL receptor containing cells, CHO and HepG2.
近期证据表明,B类I型清道夫受体(SR-BI)在极低密度脂蛋白(VLDL)代谢中发挥生理作用。据报道,SR-BI介导β-VLDL的摄取;然而,这一过程的细胞细节尚未得到充分表征。在本研究中,我们发现SR-BI将源自β-VLDL的胆固醇传递至低密度脂蛋白受体阴性且过表达SR-BI的中国仓鼠卵巢细胞(ldlA7-SRBI)。SR-BI过表达后,β-VLDL的细胞结合率提高了约3倍,β-VLDL可竞争性抑制这种结合,但高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的抑制作用较小。几乎所有结合的β-VLDL都位于细胞内,因此无法被50倍过量的未标记β-VLDL释放。β-VLDL以6 ng β-VLDL/ mg细胞蛋白·小时的速率降解。与ldlA7细胞不同,在具有功能性低密度脂蛋白受体的细胞(如CHO和HepG2细胞)中,β-VLDL的结合可被LDL竞争性抑制,这表明低密度脂蛋白受体对β-VLDL摄取有强烈影响。β-VLDL的降解与ldlA7-SRBI细胞相似。当使用荧光显微镜观察β-VLDL摄取情况时,与含低密度脂蛋白受体的细胞(CHO和HepG2)相比,β-VLDL在过表达SR-BI的细胞(ldlA7-SRBI)中呈现出不同的摄取模式。